Circio Holding ASA Statistics

Total Valuation

OSL:CRNA has a market cap or net worth of NOK 44.09 million. The enterprise value is 76.25 million.

Market Cap	44.09M
Enterprise Value	76.25M

Important Dates

The next estimated earnings date is Thursday, April 10, 2025.

Earnings Date	Apr 10, 2025
Ex-Dividend Date	n/a

Share Statistics

OSL:CRNA has 81.64 million shares outstanding. The number of shares has increased by 22.45% in one year.

Current Share Class	n/a
Shares Outstanding	81.64M
Shares Change (YoY)	+22.45%
Shares Change (QoQ)	+15.60%
Owned by Insiders (%)	3.81%
Owned by Institutions (%)	10.80%
Float	67.37M

Valuation Ratios

The trailing PE ratio is 0.44 and the forward PE ratio is 2.70.

PE Ratio	0.44
Forward PE	2.70
PS Ratio	34.03
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	8.03
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.14

Current Ratio	0.14
Quick Ratio	0.14
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-110.74%
Return on Invested Capital (ROIC)	-348.26%
Return on Capital Employed (ROCE)	117.87%
Revenue Per Employee	15,375
Profits Per Employee	1.19M
Employee Count	9
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -91.00% in the last 52 weeks. The beta is 1.50, so OSL:CRNA's price volatility has been higher than the market average.

Beta (5Y)	1.50
52-Week Price Change	-91.00%
50-Day Moving Average	0.62
200-Day Moving Average	1.10
Relative Strength Index (RSI)	38.22
Average Volume (20 Days)	828,729

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, OSL:CRNA had revenue of NOK 123,000 and earned 9.50 million in profits. Earnings per share was 1.23.

Revenue	123,000
Gross Profit	123,000
Operating Income	-50.88M
Pretax Income	9.51M
Net Income	9.50M
EBITDA	-51.35M
EBIT	-50.88M
Earnings Per Share (EPS)	1.23

Full Income Statement

Balance Sheet

The company has 2.84 million in cash and 35.00 million in debt, giving a net cash position of -32.16 million or -0.39 per share.

Cash & Cash Equivalents	2.84M
Total Debt	35.00M
Net Cash	-32.16M
Net Cash Per Share	-0.39
Equity (Book Value)	-43.16M
Book Value Per Share	-4.05
Working Capital	-43.36M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-49.23M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -41,362.60% and 7,730.08%.

Gross Margin	100.00%
Operating Margin	-41,362.60%
Pretax Margin	7,730.08%
Profit Margin	7,730.08%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OSL:CRNA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.45%
Shareholder Yield	-22.45%
Earnings Yield	21.55%
FCF Yield	n/a

Stock Splits

The last stock split was on October 4, 2023. It was a reverse split with a ratio of 0.0333333333.

Last Split Date	Oct 4, 2023
Split Type	Reverse
Split Ratio	0.0333333333

Scores

OSL:CRNA has an Altman Z-Score of -46.58. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-46.58
Piotroski F-Score	n/a